Moleculin Biotech
MBRX
MBRX
22 hedge funds and large institutions have $2.28M invested in Moleculin Biotech in 2020 Q3 according to their latest regulatory filings, with 2 funds opening new positions, 9 increasing their positions, 2 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
78% less first-time investments, than exits
New positions opened: 2 | Existing positions closed: 9
Holders
22
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$241K | |
| 2 | +$47K | |
| 3 | +$28.3K | |
| 4 |
UBS Group
Zurich,
Switzerland
|
+$12.3K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$9.17K |
Top Sellers
| 1 | -$748K | |
| 2 | -$387K | |
| 3 | -$34K | |
| 4 |
HWA
HCR Wealth Advisors
Los Angeles,
California
|
-$14K |
| 5 |
Squarepoint
New York
|
-$11K |